Business Standard

Dr Reddy's falls 3%, hits 52-week low; stock slips 10% in one month

The stock of the pharmaceutical company, which has a significant presence in the Russian market, has fallen below its previous low of Rs 4,135.90 touched on March 19, 2021

DRDO’s 2DG anti-Covid drug priced at Rs 990 per sachet: Dr Reddy's
Premium

SI Reporter Mumbai
Shares of Dr Reddy's Laboratories hit a 52-week low of Rs 4,055.85, down 3 per cent on the BSE in Thursday's intra-day trade, after Russia ordered military operations in Ukraine and reports emerged of blasts in some major Ukrainian cities.

The stock of the pharmaceutical company, which has a significant presence in the Russian market, has fallen below its previous low of Rs 4,135.90 touched on March 19, 2021. In the past one month, it has underperformed the market by falling 10 per cent as compared to 5 per cent decline in the S&P BSE Sensex.

According to

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 24 2022 | 9:54 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com